Biblioteca Humberto Rosselli Quijano
Información del autor
Documentos disponibles escritos por este autor (2)
Refinar búsqueda
[artículo]
| Título : |
A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments |
| Tipo de documento: |
texto impreso |
| Autores: |
Yvonne M. Greene, Autor ; Pierre N. Tariot, Autor ; Heather Wishart, Autor |
| Fecha de publicación: |
2023 |
| Artículo en la página: |
pp. 350-356 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Trastornos cognitivos, Indanos - efectos adversos, Indios, Esclerosis múltiple, Agentes Nootrópicos, Piperidinas. |
| Resumen: |
Cognitive dysfunction occurs in up to 65% of patients with multiple sclerosis (MS), but there is no effective treatment for the symptoms. The authors conducted a 12-week, open-pilot study to assess the efficacy and tolerability of donepezil HCl administered in patients with MS and cognitive impairment. Seventeen patients at a long-term care facility with Mini-Mental State Examination scores of ≤ 25 received 5 mg of donepezil HCl for a 4-week period, followed by 8 weeks of 10 mg of donepezil HCl. |
| Link: |
./index.php?lvl=notice_display&id=31194 |
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 350-356
|
[artículo]
| Título : |
A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments |
| Tipo de documento: |
texto impreso |
| Autores: |
Yvonne M. Greene, Autor ; Pierre N. Tariot, Autor ; Heather Wishart, Autor |
| Fecha de publicación: |
2023 |
| Artículo en la página: |
pp. 350-356 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Trastornos cognitivos, Indios, Esclerosis múltiple, Agentes nootrópicos, Piperidinas. |
| Resumen: |
Cognitive dysfunction occurs in up to 65% of patients with multiple sclerosis (MS), but there is no effective treatment for the symptoms. The authors conducted a 12-week, open-pilot study to assess the efficacy and tolerability of donepezil HCl administered in patients with MS and cognitive impairment. Seventeen patients at a long-term care facility with Mini-Mental State Examination scores of ≤ 25 received 5 mg of donepezil HCl for a 4-week period, followed by 8 weeks of 10 mg of donepezil HCl. |
| Link: |
./index.php?lvl=notice_display&id=31203 |
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 350-356
[artículo] A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments [texto impreso] / Yvonne M. Greene, Autor ; Pierre N. Tariot, Autor ; Heather Wishart, Autor . - 2023 . - pp. 350-356. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 350-356
| Palabras clave: |
Trastornos cognitivos, Indios, Esclerosis múltiple, Agentes nootrópicos, Piperidinas. |
| Resumen: |
Cognitive dysfunction occurs in up to 65% of patients with multiple sclerosis (MS), but there is no effective treatment for the symptoms. The authors conducted a 12-week, open-pilot study to assess the efficacy and tolerability of donepezil HCl administered in patients with MS and cognitive impairment. Seventeen patients at a long-term care facility with Mini-Mental State Examination scores of ≤ 25 received 5 mg of donepezil HCl for a 4-week period, followed by 8 weeks of 10 mg of donepezil HCl. |
| Link: |
./index.php?lvl=notice_display&id=31203 |
|
